EDUCATION & ACADEMIC TITLES
- PhD in Medicine, National and Kapodistrian University of Athens (2024)
- MSc in Infectious Diseases, National and Kapodistrian University of Athens (2021)
- Board Certification in Internal Medicine (2021)
- Graduate of the 13th School of Clinical Hepatology (2020)
- MD, School of Medicine, University of Patras (2014)
PROFESSIONAL EXPERIENCE
- Fellow in Infectious Diseases, 5th Department of Internal Medicine and Special Infections Unit, “Evangelismos” General Hospital of Athens (2023–2025)
- Consultant, 3rd Department of Internal Medicine, Metropolitan General (2022–2023)
- Resident in Internal Medicine, 4th University Department of Internal Medicine, “Attikon” University General Hospital (2016–2020)
- Resident in Internal Medicine, 1st Department of Internal Medicine, Kalamata General Hospital (2015–2016)
MEMBERSHIPS & EDITORIAL BOARD POSITIONS
- Member, European Society of Clinical Microbiology and Infectious Diseases
- Member, Hellenic Society for the Study and Control of AIDS
- Member, Hellenic Society for Infectious Diseases
- Member, Hellenic Society for Chemotherapy
- General Secretary, National Board of the Scientific Society of Medical Students of Greece (2013–2015)
HONORS & AWARDS
- 2nd Prize for Oral Presentation – Immunogenicity of the seasonal influenza vaccine in patients with Multiple Sclerosis under disease-modifying therapy: a single-center observational study.
22nd Panhellenic Congress on Infections, March 2023, Athens (Oral Presentation EA09) - 3rd Prize for Best Paper – Two uncommon causes of hemorrhagic diathesis in a patient on coumarin anticoagulants.
4th Panhellenic Congress of Continuing Education in Internal Medicine, February 2018, Thessaloniki (Oral Presentation PA47) - Honorary Distinction as Honorary President of the Patras Branch of the Scientific Society of Medical Students of Greece, September 2014
Publications
- Marantos T, Kyriazopoulou E, Angelakis E, Kitsos D, Chondrogianni M, Mpizta G, Papadopoulos A, Giannopoulos S, Voumvourakis K, Tsiodras S. Immunogenicity of a seasonal influenza and a pneumococcal polysaccharide vaccine in multiple sclerosis patients under disease modifying therapies: A single-center prospective study. Vaccine. 2024; 42:126001
- Marantos T, Kyriazopoulou E, Lekakis V, Voumvourakis KI, Tsiodras S. Immunogenicity and safety of vaccines in multiple sclerosis: A systematic review and meta-analysis. J Neurol Sci 2024; 15:456:122852
- Zheng H, Rao AM, Dermadi D, Toh J, Murphy Jones L, Donato M, Liu Y, Su Y, Dai CL, Kornilov SA, Karagiannis M, Marantos T, Hasin-Brumshtein Y, He YD, Giamarellos-Bourboulis EJ, Heath JR, Khatri P. Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses. Immunity 2021; 54:753-68
- Kyriazopoulou E, Panagopoulos P, Metallidis S, Dalekos GN, Poulakou G, Gatselis N, Karakike E, Saridaki M, Loli G, Stefos A, Prasianaki D, Georgiadou S, Tsachouridou O, Petrakis V, Tsiakos K, Kosmidou M, Lygoura V, Dareioti M, Milionis H, Papanikolaou IC, Akinosoglou K, Myrodia DM, Gravvani A, Stamou A, Gkavogianni T, Katrini K, Marantos T, Trontzas IP, Syrigos K, Chatzis L, Chatzis S, Vechlidis N, Avgoustou C, Chalvatzis S, Kyprianou M, van der Meer JW, Eugen-Olsen J, Netea MG, Giamarellos-Bourboulis EJ. An open label trial of anakinra to prevent respiratory failure in COVID-19. Elife 2021; 10: e66125
- Fermeli D, Marantos T, Liarakos A-L, Panayiotakopoulos G, Dedes V, Panoutsopoulos G. Linezolid: a Promising Agent for the Treatment of Multiple and Extensively Drug-Resistant Tuberculosis. Folia Med (Plovdiv) 2020; 62:444-52
- Fragkou P, Thomas K, Sympardi S, Liatsos G, Pirounaki M, Sambatakou S, Marantos T, Karofylakis E, Dourakis S, Tsiodras S, Kavvatha D. Clinical characteristics and outcomes of measles outbreak in adults: A multicenter retrospective observational study of 93 hospitalized adults in Greece. J Clin Virol 2020 doi: 10.1016/j.jcv.2020.104608
- Athanasakis K, Pliarchopoulou F, Naoum V, Psarrakis C, Tziolos N, Marantos T, Damoulari C, Chounta A. A cost of illness analysis of hepatocellular carcinoma for the Greek healthcare setting. Gastroenterol Hepatol Bed Bench 2020; 13:219-22
